182 related articles for article (PubMed ID: 21629141)
21. Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.
Leivo T; Sarmela J; Enckell-Aaltonen M; Dafgård Kopp E; Schmitt C; Toft PB; Sigurdsson H; Uusitalo M
BMC Ophthalmol; 2020 Mar; 20(1):103. PubMed ID: 32178641
[TBL] [Abstract][Full Text] [Related]
22. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
Kan LW; Leu YS; Tzen CY; Wu CH
Am J Otolaryngol; 2011; 32(6):620-3. PubMed ID: 21168242
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological analysis of periocular sebaceous gland carcinoma.
Yoon JS; Kim SH; Lee CS; Lew H; Lee SY
Ophthalmologica; 2007; 221(5):331-9. PubMed ID: 17728556
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy for localized sebaceous carcinoma of the eyelid: a retrospective analysis of 83 patients.
Takagawa Y; Tamaki W; Suzuki S; Inaba K; Murakami N; Takahashi K; Igaki H; Nakayama Y; Shigematsu N; Itami J
J Radiat Res; 2019 Oct; 60(5):622-629. PubMed ID: 31271440
[TBL] [Abstract][Full Text] [Related]
25. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.
Kaliki S; Ayyar A; Dave TV; Ali MJ; Mishra DK; Naik MN
Eye (Lond); 2015 Jul; 29(7):958-63. PubMed ID: 25998946
[TBL] [Abstract][Full Text] [Related]
26. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant Systemic Chemotherapy in the Management of Extensive Eyelid Sebaceous Gland Carcinoma: A study of 10 Cases.
Kaliki S; Ayyar A; Nair AG; Mishra DK; Reddy VA; Naik MN
Ophthalmic Plast Reconstr Surg; 2016; 32(1):35-9. PubMed ID: 25675161
[TBL] [Abstract][Full Text] [Related]
28. Selective removal of sebaceous gland carcinoma of the lower eyelid with orbital infiltration.
Detorakis ET; Ioannakis K; Giatromanolaki A; Sivridis E; Drakonaki E; Kozobolis VP
Ophthalmic Surg Lasers Imaging; 2007; 38(5):413-6. PubMed ID: 17955850
[TBL] [Abstract][Full Text] [Related]
29. Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis.
Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
Exp Eye Res; 2014 Jan; 118():46-52. PubMed ID: 24216315
[TBL] [Abstract][Full Text] [Related]
30. [A case of giant sebaceous gland carcinoma without adequate treatment].
Enomoto E; Kamura Y; Nohara M; Kaneko A; Tsuji H; Hasegawa H; Sugitani M
Nippon Ganka Gakkai Zasshi; 2000 Oct; 104(10):740-5. PubMed ID: 11081311
[TBL] [Abstract][Full Text] [Related]
31. 14-year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management.
Lam SC; Li EYM; Yuen HKL
Br J Ophthalmol; 2018 Dec; 102(12):1723-1727. PubMed ID: 29459429
[TBL] [Abstract][Full Text] [Related]
32. Multidisciplinary management of primary adenoid cystic carcinoma of the eyelid with perineural invasion.
Bui M; Frank SJ; Nasser QJ; El Sawy T; McLemore MS; Morrison WH; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2013; 29(6):e143-6. PubMed ID: 23446295
[TBL] [Abstract][Full Text] [Related]
33. Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid - a population-based analysis.
Lee IJ; Koh JY
Orbit; 2019 Aug; 38(4):261-268. PubMed ID: 30373440
[No Abstract] [Full Text] [Related]
34. Treatment of Metastatic Eyelid Carcinoma.
Bonavolontà P; Dell'Aversana Orabona G; Abbate V; Iaconetta G; Bonavolontà G; Califano L
J Craniofac Surg; 2017 Nov; 28(8):e722-e725. PubMed ID: 28885435
[TBL] [Abstract][Full Text] [Related]
35. Comparison of posterior lamellar resection versus lumpectomy for initial management of localized tarsal conjunctival sebaceous carcinoma in 54 cases.
Lally SE; Rao R; Shields JA; Shields CL
Indian J Ophthalmol; 2018 Sep; 66(9):1295-1300. PubMed ID: 30127144
[TBL] [Abstract][Full Text] [Related]
36. Sebaceous Carcinoma of the Ocular Region: The 2014 Professor Winifred Mao Lecture.
Shields JA; Saktanasate J; Lally SE; Carrasco JR; Shields CL
Asia Pac J Ophthalmol (Phila); 2015; 4(4):221-7. PubMed ID: 26147013
[TBL] [Abstract][Full Text] [Related]
37. Diffuse pattern, orbital invasion, perineural invasion and Ki-67 are associated with nodal metastasis in patients with eyelid sebaceous carcinoma.
Gu X; Xie M; Luo Y; Song X; Xu S; Fan X
Br J Ophthalmol; 2023 Jun; 107(6):756-762. PubMed ID: 35063931
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea.
Choi YJ; Jin HC; Lee MJ; Kim N; Choung HK; Khwarg SI
Jpn J Ophthalmol; 2014 Jul; 58(4):327-33. PubMed ID: 24763914
[TBL] [Abstract][Full Text] [Related]
39. [Sebaceous carcinoma of eyelid presenting as dry-eye-syndrome (author's transl)].
Henriquez AS; Arruga A
Klin Monbl Augenheilkd; 1979 Sep; 175(3):318-21. PubMed ID: 529739
[TBL] [Abstract][Full Text] [Related]
40. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
